I have a strong background in oncology where I have extensively worked with human tumor samples and primary cells to characterize and identify new treatment vulnerabilities. In my current role, I am using diverse tools like spatial transcriptomics, In situ sequencing and spatial epigenomics to characterize an array of tissue types from normal and diseased states.
